Despite Concerns About Research Budgets, Genomic Tools and MDx Stocks Rise In 1H 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – While there is widespread concern about potential cutbacks in federal spending for research both in the US and abroad, that concern did little to dampen the stock performance of many of the firms in the GenomeWeb Daily News Index in the first half of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.